Report: COVID & Beyond
The COVID-19 pandemic, declared by the WHO in March 2020, has had a profound impact on public health, economics and society. The pandemic sparked an unprecedented global effort to develop and deploy new vaccines. The success, development and approval of several COVID-19 vaccines have been hailed as a triumph of science. Click below to view the videos of interviews with Dr Francisco Gimenez, Radu Ganescu and MEP Tomislav Sokol.
The introduction of COVID-19 vaccines in Europe has required mass immunisation campaigns on a scale never seen before. While supply constraints have led governments to prioritise those at the highest risk, vaccines will be offered to adults of all ages. Studies are also underway to test the safety and efficacy of COVID-19 vaccines in children and adolescents. For many people, COVID-19 vaccines are the first vaccines they have been offered in decades. Thousands of health workers have been mobilised to join the immunisation delivery effort. The experience of communicating about vaccines to people of all ages holds lessons for the future, while the development of infrastructure for vaccine delivery presents opportunities for increasing uptake of other vaccines.
To provide a snapshot of the rollout of COVID-19 vaccines across Europe in the spring of 2021, the Coalition for Life-Course Immunisation asked its network of members and supporters three key questions:
Has COVID-19 raised the profile of vaccination across all ages and stages of life (lifecourse vaccination) in your country?
How have (a) your government, and (b) your fellow citizens responded to the COVID-19 vaccination?
What needs to happen post-COVID in your country to encourage life-course immunisation and all the vaccination programs that make a resilient healthcare provision?
The results presented here offer subjective insights from immunisation experts on the introduction of COVID-19 vaccines. The report also looks beyond the pandemic to explore the legacy of COVID and its potential to shape the future of life-course immunisation.
OTHER REPORTS
Vaccines Prevent Disease Across the Life Course
The Life Course Immunisation Summit stressed the urgent need for improved public education, increased funding and innovative research on adult vaccination. The conference united European vaccine experts who called for cohesive EU health policies that address...
Global Health Podcast Special on COVID-19
A report on the key discussions and takeaways Dive into the comprehensive findings of our latest Global Health Podcast Series. This pivotal report offers a wealth of knowledge and expert opinions on critical public health topics, including COVID-19 vaccine...
Data-informed decision-making
Data-informed Decision-making: Driving life-course immunisation in National Immunisations Programs (NIPs) CLCI works towards a vision where everyone, regardless of age or life stage, can be vaccinated and shielded from vaccine-preventable diseases (VPDs)....
JOIN US
Contribute to global public health policy and protect population health.
Stride forward with us to prevent disease through widespread immunisation. Together, we can redefine health landscapes and contribute to a world where everyone, regardless of age, can be protected from vaccine-preventable diseases.
GET IN TOUCH
For general enquires, email:
secretariat@cl-ci.org
For research requests and opportunities, email:
research@cl-ci.org